Literature DB >> 11027448

Immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins induces long-term duration cross-reactive antibodies with heart functional and structural alterations in young and aged mice.

C C Motrán1, R E Fretes, F M Cerbán, H W Rivarola, E Vottero de Cima.   

Abstract

The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P concensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. The immunization of BALB/c mice with R13 synthetic peptide coupled to a carrier protein (OVA) induces specific (anti-R13) and autoreactive (anti-H13 and anti-heart) antibodies as well as heart functional alterations. Since aged human and experimental animals are impaired in their responses to most foreign antigens but they produce greater amounts of autoantibodies, in this work we used aged mice as an experimental model able to exaggerate the autoimmune component of the R13-induced response in case it was present. We studied whether these antibodies generated in the absence of the parasite would induce pathological changes in heart tissues. The levels of antibodies against R13 (foreign antigen) and H13 (autoantigen) studied comparatively in 2- and 12-month-old mice 10 days after the third immunization with R13 coupled to OVA were, as we expected for a foreign antigen, higher in almost all sera from 2-month-old mice tested than in sera from 12-month-old mice. Besides, these specific and cross-reactive antibody response remain elevated as long as 150 days post third immunization. In addition, the isotype pattern that recognizes R13 and the self-sequence H13 showed no differences between sera from young and aged mice. Moreover, when ECG traces were obtained from immunized mice, the heart functional alterations observed at 10 days continued at 80 and 150 days after the third immunization, showing an association with the levels of antibodies. In addition, despite the fact that the heart tissue morphology showed no alterations 10 days post third immunization, several abnormalities in the tissue architecture were revealed at 80 and 150 days post third immunization. This report demonstrates the biological relevance of R13-induced cross-reactive antibodies in some of the electrophysiologic and histological changes found in T. cruzi-infected mammalians. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027448     DOI: 10.1006/clim.2000.4919

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

Review 1.  Infection, mimics, and autoimmune disease.

Authors:  N R Rose
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.

Authors:  Kevin M Bonney; David M Engman
Journal:  Am J Pathol       Date:  2015-04-07       Impact factor: 4.307

3.  Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Authors:  Kevin M Bonney; Joann M Taylor; Edward B Thorp; Conrad L Epting; David M Engman
Journal:  Parasitol Res       Date:  2015-01-11       Impact factor: 2.289

Review 4.  Chagas heart disease pathogenesis: one mechanism or many?

Authors:  Kevin M Bonney; David M Engman
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

5.  A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins.

Authors:  Juan S Leon; Melvin D Daniels; Krista M Toriello; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity.

Authors:  Kevin M Bonney; Joann M Taylor; Melvin D Daniels; Conrad L Epting; David M Engman
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

7.  3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.

Authors:  Carolina P Knubel; Fernando F Martínez; Eva V Acosta Rodríguez; Andrés Altamirano; Héctor W Rivarola; Cintia Diaz Luján; Ricardo E Fretes; Laura Cervi; Claudia C Motrán
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease.

Authors:  André Azevedo Reis Teixeira; Luis Rodriguez Carnero; Andréia Kuramoto; Fenny Hui Fen Tang; Carlos Hernique Gomes; Natalia Bueno Pereira; Léa Campos de Oliveira; Regina Garrini; Jhonatas Sirino Monteiro; João Carlos Setubal; Ester Cerdeira Sabino; Renata Pasqualini; Walter Colli; Wadih Arap; Maria Júlia Manso Alves; Edécio Cunha-Neto; Ricardo José Giordano
Journal:  iScience       Date:  2021-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.